Table 4.
Univariate and multivariate analysis using Cox's proportional hazard model
| Variable | n | Univariate a | Multivariate b | ||
|---|---|---|---|---|---|
| p value | HR c | 95% CI d | p-value | ||
| Total | 81 | ||||
| Sex | |||||
| Male vs. Female | 51 vs. 30 | 0.357 | |||
| Age (years) | |||||
| ≥ 65 vs. < 65 | 43 vs. 38 | 0.776 | |||
| BMI (kg/m2) | |||||
| < 18.5 vs. ≥ 18.5 | 8 vs. 73 | 0.080 | |||
| pStagee | |||||
| pStage III vs. pStage II | 34 vs. 47 | < 0.001 | 3.08 | 1.41-7.22 | 0.005 |
| Histological type | |||||
| Undifferentiated vs. Differentiated | 49 vs. 32 | 0.856 | |||
| Postoperative peak-CRP (mg/dl) | |||||
| ≥ 8.1 vs. < 8.1 | 45 vs. 36 | 0.658 | |||
| Complication (C-Df ≥ II) | |||||
| Positive vs. Negative | 12 vs. 69 | 0.480 | |||
| PIAC (weeks) | |||||
| ≥ 7 vs. < 7 | 23 vs. 58 | 0.004 | 2.45 | 1.13-5.29 | 0.024 |
| Cumulative S-1 dose/BSAg (mg/m2) | |||||
| < 12,000 vs. ≥12,000 | 40 vs. 41 | 0.002 | 3.27 | 1.43-8.37 | 0.004 |
a Analyzed by Log Rank (Mantel-Cox) test;
b Analyzed by Cox's proportional hazard model;
c HR: hazard ratio, d CI: confidence interval;
e Japanese Classification of Gastric Carcinoma;
f C-D: Clavien-Dindo classification, g BSA: body surface area.